Skip to main content
Logo

Search form

  • Home
  • Who we are
    • About Synnovis
    • Our people
    • Our services
    • Innovation
    • Quality
  • What we do
    • Departments and laboratories
    • Phlebotomy training
    • Primary Care Information Centre
    • Swiftqueue
  • Tests and results
    • Test index
    • Tests A-Z
    • Test information
    • UKAS Accreditation
  • Service Users
    • Secondary Care NHS Trusts
    • Primary Care Information Centre
    • Private Users
  • Resources
    • News and press
    • Articles and papers
    • Synnovis Policies, User Guides and Documents
    • Transformation
    • Cyberattack Information
  • Join us
    • Your career
    • Working with us
    • Career pathways
    • Current vacancies
    • Training and development
  • Contact us
    • Locations
    • Key contacts
    • Commercial Testing & Partnership Enquiries
    • Customer service
  • Welcome, Sign in or Register
Menu

Microbiology Laboratory at St Thomas' Hospital

Laboratory overview

Our laboratory offers a comprehensive diagnostic and interpretative service for the management of bacterial, parasitic and mycological (non-dermatology) infections 

We have tripartite working with partnership between Medical Microbiologists, Clinical Scientists and Biomedical Scientists. We are a modern laboratory which utilises cutting edge technology for timely bacterial identification and susceptibility testing. The laboratory processes about 300,000 samples per annum. Positive results are authorised by the Medical Microbiologist who are also available to give advice on clinical interpretation and treatment. Fully integrated with the virology laboratory which is co-located enabling efficient flow of specimens requiring multiple tests.

Microbiology at St Thomas’s provides a comprehensive range of services 7 days a week with a 24/7 out of hours service.   Our staff are composed of a mix of  skilled and experienced scientists and medical laboratory assistants, enabling us to deliver a first rate quality laboratory service.

Key features:

  • UKAS accredited 
  • Regular review of laboratory processes and uptake of new technology, automation, near patient testing as appropriate to improve diagnosis and turn-around times.

           -MALDI-TOF mass spectrometry enables more rapid identification of organisms, including those causing bloodstream infection.
           -Molecular diagnostics for faecal pathogens provides higher sensitivity and reduced turnaround time to result
           -Automated urinalysis

  • On site new containment Level 3 suite facilities with specialised Mycobacterial analysis and rapid molecular diagnostics but also enables rapid processing of other high risk infection specimens.
  • Fully integrated with Infectious Diseases and Medical Microbiology clinical team and Infection Control Services

            -Our services have demonstrably contributed to improved diagnosis and treatment of Healthcare Associated Infections e.g. MRSA and C.difficile.
            -Our innovations have led to a significant reduction in hospital acquired infection rates.

  • Departments and laboratories
  • Phlebotomy training
  • Primary Care Information Centre
  • Swiftqueue
Last updated on 15/01/2014
  • Articles and papers
  • our people
  • Contacts
view our tests
Tuesday, 2 April, 2013
Clustering of antimicrobial resistance outbreaks across bacterial species in the intensive care unit
There are frequent reports of intensive care unit (ICU) outbreaks due to transmission of particular antibiotic-resistant bacteria.
Anne L. M. Vlek , Ben S. Cooper , Theodore Kypraios , Andy Cox , , Olga Tosas Auguet
Sunday, 17 February, 2013
Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study
There is increasing evidence that invasive fungal disease (IFD) is more likely to occur in non-neutropenic patients in critical care units.
Harrison D , Muskett H , Harvey S , Grieve R , Shahin J , Patel K , Sadique Z , Allen E , Dybowski R , Jit M , , Kibbler C , Barnes R , Soni N , Rowan K.
Thursday, 10 January, 2013
Low prevalence of meticillin-resistant Staphylococcus aureus carriage at hospital admission: implications for risk-factor-based vs universal screening
There is debate over the optimal policy for detecting meticillin-resistant Staphylococcus aureus (MRSA) colonization at hospital admission.
J. A. Otter , M. T. Herdman , B. Williams , O. Tosas , , G. L. French
Monday, 7 January, 2013
A genomic portrait of the emergence, evolution and global spread of a methicillin-resistant Staphylococcus aureus pandemic
The widespread use of antibiotics in association with high-density clinical care has driven the emergence of drug-resistant bacteria that are adapted to thrive in hospitalized patients.
Matthew T.G. Holden , Li-Yang Hsu , Kevin Kurt , Lucy A. Weinert , Alison E. Mather , Simon R. Harris , Birgit Strommenger , Franziska Layer , Wolfgang Witte , Herminia de Lencastre , Robert Skov , Henrik Westh , Helena Žemličková , Geoffrey Coombs , Angela M. Kearns , Robert L.R. Hill , , Ian Gould , Vanya Gant , Jonathan Cooke , Giles F. Edwards , Paul R. McAdam , Kate E. Templeton , Angela McCann , Zhemin Zhou , Santiago Castillo-Ramírez , Edward J. , Lyndsey O. Hudson , Mark C. Enright , Francois Balloux , David M. Aanensen , Brian G. Spratt , J. Ross Fitzgerald , Julian Parkhill , Mark Achtman , Stephen D. Bentley , Ulrich Nübel
Thursday, 3 January, 2013
Selection for qacA carriage in CC22 but not CC30 MRSA bloodstream infection isolates during a successful institutional infection control programme.
The increasing use of chlorhexidine for methicillin-resistant Staphylococcus aureus (MRSA) decolonization raises concerns about reduced susceptibility.
Otter JA , Patel A , Cliff PR , Halligan EP , Tosas O ,
List Grid
Lisa Bryan
Microbiology Operations Manager
Angela Menezes
Infection Sciences Quality Manager
Natasha Odubade
Quality Officer
Florina Mamaische
Quality Manager

Infection Sciences Department at St Thomas' Hospital

020 7188 8008
St Thomas' Hospital
North Wing - 5th Floor
Westminster Bridge Road
London SE1 7EH
Core opening hours: Monday-Friday 0900-1730


Last updated: 15/01/2014

eMail alerts and news

Sign up with Viapath to receive our newsletter and hear about our scientific events.
Privacy policy

Follow us

Twitter LinkedIn RSS

Site details

  • Privacy policy
  • Cookies
  • Terms of use
  • Accessibility
  • Feedback

Working with our NHS service partners to set the standard for the future of pathology

 

Gyu's and St Thomas'
King's College Hospital

 

Viapath is a founding member of The Association of Independent Pathology Providers (AIPP), which is a trade association representing innovative research-based diagnostic testing companies. 

Copyright 2014-2025 Synnovis Group LLP. Synnovis, the Synnovis logo and Nutris are registered trademarks of Synnovis Group LLP.

Home
Who we are
  • About Synnovis
  • Our people
  • Our services
  • Innovation
  • Quality
What we do
  • Departments and laboratories
  • Phlebotomy training
  • Primary Care Information Centre
  • Swiftqueue
Our tests
  • Test index
  • Tests A-Z
  • Test information
  • UKAS Accreditation
Service users
News and media
  • News and press
  • Articles and papers
  • Synnovis Policies, User Guides and Documents
  • Transformation
  • Cyberattack Information
Careers
  • Your career
  • Working with us
  • Career pathways
  • Current vacancies
  • Training and development
Contact us
  • Locations
  • Key contacts
  • Commercial Testing & Partnership Enquiries
  • Customer service
Close menu